GlassScriptPhysician profile
Bryan J Beck
NPI 1760986467
$996.71
in general payments reported to CMS, 2019-2025
19 companies · $502 in 2025
The $502 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $125 · 2022: $162 · 2023: $99.95 · 2024: $107 · 2025: $502.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $609 · Education: $99.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $609.27 |
| Education | $99.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $162.49 | 2022 | |
| Genzyme Corporation | $158.45 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $99.95 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $70.59 | 2025 | Tezspire, Fasenra |
| Insmed, INC. | $70.39 | 2025 | Arikayce |
| Genentech USA, INC. | $55.32 | 2024-2025 | Xolair |
| Merck Sharp & Dohme LLC | $49.68 | 2025 | Zerbaxa, Winrevair |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.57 | 2024-2025 | Ofev |
| Axsome Therapeutics, INC. | $44.36 | 2024-2025 | Sunosi |
| Lilly USA, LLC | $36.68 | 2025 | Zepbound |
| Lantheus Medical Imaging, INC. | $33.98 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $28.38 | 2025 | Dupixent |
| Glaxosmithkline, LLC. | $24.41 | 2025 | Nucala |
| United Therapeutics Corporation | $24.29 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.75 | 2025 | Glassia |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $20.14 | 2025 | Prolastin-C Liquid |
| Jazz Pharmaceuticals INC. | $19.55 | 2025 | |
| Baxter Healthcare | $17.08 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Viatris Specialty LLC | $15.65 | 2025 | Yupelri |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Beck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.